The histology of Sjogren's syndrome, which is defined as keratoconjunctivitis sicca (KCS) with xerostomia and rheumatoid arthritis, for the purpose of this communication, has been studied post mortem either in single cases or in series of not more than three patients (Sjogren, I933; Holm, I949;  Allington, I950; Bohm, I950; Ellman, Weber, and Goodier, I95I; Morgan and Raven, 1952; Cardell and Gurling, I954; Szanto, Farkas, and Gyulai 1957; Funatsu and Eguchi, I957; Bucher and Reid, 1959;  Bain, I960; Bloch, Buchanan, Wohl, and Bunim, I965).
The lacrimal and salivary glands, and the mucous glands of the respiratory tract, mouth, and upper oesophagus are typically involved. However, most of the observations on lacrimal gland structure were recorded in severe cases of KCS and in patients who had died as a result of the severe complications of arthritis or another connective tissue disease. The primary purpose of this study was to investigate the histology of the lacrimal gland in patients currently suffering from KCS.
Patients with KCS and xerostomia, but no evidence of connective tissue disease, may be classified as suffering from the "sicca syndrome" (Bloch and others, I965) . Lacrimal gland tissue from such patients was studied to determine any features that may differentiate the "sicca syndrome" from Sjogren's syndrome.
Furthermore, reduced Schirmer II tear tests may be demonstrated in a number of rheumatoid arthritic patients who have no evidence of punctate or filamentary keratitis. For study purposes, these patients may be regarded as cases of "possible" Sjogren's syndrome. Lacrimal gland biopsies were obtained from a sample of patients with "possible" Sj6gren's syndronme in an attempt to elucidate the validity of this classification.
According to Manschot (i 96 I), systemic corticosteroids or adrenocorticotrophic hormone therapy may be effective in controlling acute exacerbations of Sjogren's syndrome and, therefore, may be expected to modify the histological appearances of the lacrimal gland. Thus particular note was taken of any history of systemic steroid therapy.
Materials and methods

PATIENTS STUDIED
Biopsies of the lacrimal gland were obtained from 29 female patients (eighteen Sjogren's syndrome, five sicca syndrome, and six "possible" Sjogren's syndrome). In addition, the lacrimal glands of ten age-matched patients, who had died from a variety of medical disorders not known to be related to rheumatoid arthritis or connective tissue disease and who had no history of ocular disease, were examined post mortem (Table I) . (Ropes, Bennett, Cobb, Jacox, and Jessar, 1959) .
LACRIMAL GLAND BIOPSY TECHNIQUE
Since removal of part of the palpebral portion of the lacrimal gland entails destruction of the excretory ducts, the orbital section was chosen for biopsy. Each patient understood the reason for the operation and that it was carried out on a voluntary basis. After infiltration with local anaesthesia, 2 per cent. lignocaine without adrenaline, the skin was incised for a distance of I *5 cm. from the lateral orbital tubercle towards the medical canthus, o 5 cm. below and parallel to the superior orbital margin. Underlying fascia and muscle were separated by blunt dissection until the smoky-blue periorbital membrane was identified where it is closely attached to the rim of the orbit. Incision of the periorbital membrane resulted in protrusion of periorbital fat which was easily replaced with a probe. Toothed forceps were inserted into the superior lateral angle of the orbital roof and a piece of lacrimal gland tissue, no greater than I cu. mm., was abscised. The specimen was transported in formal saline. The skin wound was closed with three interrupted black silk sutures, no haemostatic or subcuticular stitches being necessary. Eyelid appearances returned to normal within I4 days and no complications were encountered. Histology was studied on paraffin sections 6 V. thick stained by haematoxylin and eosin. Considerable care was taken to give the pathologist no information regarding the source of the lacrimal tissue.
Results Table I shows the range of disorders from which the patients were suffering. Two of the 24 rheumatoid arthritic patients also had systemic lupus erythematosus and three of the five "sicca syndrome" group also had osteoarthritis. There was no significant difference in the mean age and age range of the groups studied.
Four distinct histological stages were recognized in this study ( The remaining seventeen Sjogren's syndrome and five sicca syndrome patients all showed abnormal lacrimal gland tissue (Table i) .
Mild chronic inflammation (Stage i) was detected in one of the sicca syndrome patients who was also suffering from primary biliary cirrhosis.
This was a 67-year-old woman with a 6-year history of liver disease without arthropathy and a 6 months' history of dry eyes. Salivary duct autoantibodies were present but there was no clinical, serological, or x-ray evidence of rheumatoid arthritis.
The only other patient with mild chronic inflammation (Stage I) was a 75-year-old woman with a 6-year history of dry eyes and a dry mouth (sicca syndrome).
Eleven patients, nine with Sjogren's syndrome and two with the sicca syndrome, had severe chronic inflammatory changes (Stage II) and the late results of inflammation (Stage III) were recorded in the remaining nine patients, eight with Sjogren's syndrome and one with sicca syndrome (Table II) . No histological features distinguished the lacrimal glands of patients with Sjogren's syndrome from those with the sicca syndrome. Severity of lacrimal gland destruction tended to be greater with increased duration of ocular disease (Table II) . Thus none of the eight patients who had suffered from KCS for less than 3 years had Stage III changes. On the other hand, three patients with a 3-to 5-year history showed only mild or severe chronic infiltration (Stages I and II).
The groups are too small to compare with respect to severity of arthritis. Five of the patients with Sj6gren's syndrome had received steroid therapy for periods varying from 2 to I o years in an average daily dose of 5 mg. prednisolone or its equivalent per day. Stage III (late) changes were described in four and Stage II (severe chronic) in one case. Steroid therapy had not prevented involvement of the lacrimal glands in these patients. All five patients had suffered from Sjogren's syndrome for more than 5 years and had received systemic steroids during that time. Nevertheless, no difference in histology could be determined between these patients and the remaining group who had never received systemic steroids and who had also suffered from KCS for more than 5 years. In our series the lacrimal glands of four patients with sicca syndrome were examined and no features were found to differentiate them from patients with Sjogren's syndrome.
In the second group of three patients, Bloch and others (I965) described the pathology in the parotid gland of a 66-year-old woman who had suffered from Sjogren's syndrome for i I years, and stated that the lacrimal gland changes were similar.
They identified infiltration with small mononuclear cells and lymphocytes and noted that remnants of acinar components were sparse, located at the periphery of the lobules. Some of the ducts were distended with secretion, but the normal architecture of the lobules was preserved. It is interesting that they, like Cardell and Gurling, were able to identify occasional plasma cells.
In our series plasma cells were not identified once lymphocytic infiltration had begun. In our series, neither the ten age-matched patients examined post mortem, nor the six patients with "possible" Sj6gren's syndrome had abnormal lacrimal gland tissue. This would suggest that the definition of Sjogren's syndrome as a chronic inflammatory disease is valid, and it would appear from our biopsy findings that KCS without evidence of connective tissue disease is also a chronic inflammatory disorder. However, Radnot (I939) recorded over 30 years ago that patients over the age of 50 years undergo progressive atrophy of the lacrimal glands and that infiltration with lymphocytes is a normal occurrence in this and older age groups. The mean age of the control group in this series was 64 years, yet no abnormalities of the lacrimal glands were detected. It would appear reasonable to suggest that more extensive examinations of "normal" lacrimal gland tissue, especially in older age groups, should be undertaken.
Summary
Histology of the lacrimal gland was studied in a series of 29 female patients, eighteen of whom had Sjogren's syndrome, five the sicca syndrome, and six "possible" Sjogren's syndrome. Furthermore, the lacrimal glands of ten patients with no history of ocular or connective tissue disease were examined post mortem.
The appearances were classified into normal, mild chronic inflammation, severe chronic inflammation, and late fibrosis (Stages 0, I, II, and III). Both the controls and the "possible" cases of Sjogren's syndrome had normal lacrimal glands. Those with Sjogren's syndrome and the "sicca syndrome" showed abnormal lacrimal gland histology, the extent of which was related to the duration of the keratoconjunctivitis sicca. No specific features distinguished the lacrimal glands of Sjogren's syndrome from those of the sicca syndrome. In addition, long-term systemic steroid therapy did not seem to have reduced the extent of lacrimal gland pathology in the series examined.
